Literature DB >> 8297639

Prediction of cancer incidence in the Nordic countries up to the years 2000 and 2010. A collaborative study of the five Nordic Cancer Registries.

A Engeland1, T Haldorsen, S Tretli, T Hakulinen, L G Hörte, T Luostarinen, K Magnus, G Schou, H Sigvaldason, H H Storm.   

Abstract

Entities:  

Mesh:

Year:  1993        PMID: 8297639

Source DB:  PubMed          Journal:  APMIS Suppl        ISSN: 0903-465X


× No keyword cloud information.
  12 in total

Review 1.  Conditions in utero and cancer risk.

Authors:  Tom Grotmol; Elisabete Weiderpass; Steinar Tretli
Journal:  Eur J Epidemiol       Date:  2006-09-13       Impact factor: 8.082

Review 2.  Current concepts in the role of intravesical instillations in the therapy and prophylaxis of superficial transitional-cell cancer of the bladder. The Finnbladder Research Group.

Authors:  O Alfthan; K Jauhiainen; E Kaasinen; T Liukkonen
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

3.  Deteriorating stage profile of gastrointestinal cancer in Finland.

Authors:  Hannu Paimela; Oksala Niku; Mustonen Harri
Journal:  Int J Gastrointest Cancer       Date:  2005

4.  Breast cancer incidence and familiality in Iceland during 75 years from 1921 to 1995.

Authors:  H Tulinius; H Sigvaldason; G Olafsdóttir; L Tryggvadóttir; K Bjarnadóttir
Journal:  J Med Genet       Date:  1999-02       Impact factor: 6.318

5.  Case-control study of squamous cell cancer of the oral cavity in Denmark.

Authors:  T Bundgaard; J Wildt; M Frydenberg; O Elbrønd; J E Nielsen
Journal:  Cancer Causes Control       Date:  1995-01       Impact factor: 2.506

6.  Nuclear DNA analysis and prognosis in carcinoma of the thyroid gland. A nationwide study in Iceland on carcinomas diagnosed 1955-1990.

Authors:  J G Jónasson; J Hrafnkelsson
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

7.  The impact of smoking habits on lung cancer risk: 28 years' observation of 26,000 Norwegian men and women.

Authors:  A Engeland; T Haldorsen; A Andersen; S Tretli
Journal:  Cancer Causes Control       Date:  1996-05       Impact factor: 2.506

8.  TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival.

Authors:  Pedro Kringen; Yun Wang; Vanessa Dumeaux; Jahn M Nesland; Gunnar Kristensen; Anne-Lise Borresen-Dale; Anne Dorum
Journal:  BMC Cancer       Date:  2005-10-17       Impact factor: 4.430

9.  Empirical evaluation of prediction intervals for cancer incidence.

Authors:  Bjørn Møller; Harald Weedon-Fekjaer; Tor Haldorsen
Journal:  BMC Med Res Methodol       Date:  2005-06-10       Impact factor: 4.615

10.  Increased mortality rates in young and middle-aged patients with malignant germ cell tumours.

Authors:  S D Fosså; N Aass; S Harvei; S Tretli
Journal:  Br J Cancer       Date:  2004-02-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.